Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lushun Jiang"'
Autor:
Wei Yu, Linyan Zeng, Xiang Lian, Lushun Jiang, Hao Xu, Wenhui Guo, Beiwen Zheng, Yonghong Xiao
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Objectives The aim of this work was to assess dynamic cytokine profiles associated with bloodstream infection (BSI) caused by Klebsiella pneumoniae (Kpn) and investigate the clinical features associated with mortality. Methods A total of 114
Externí odkaz:
https://doaj.org/article/a9bf6ea939a54f86ae80c69af6e8fd0d
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-14 (2023)
Abstract Background Our study aimed to compare the predictive performance of different hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B patients receiving entecavir or tenofovir, including discrimination, calibration, negative
Externí odkaz:
https://doaj.org/article/c29c28479e894975bb3d6295d9554da0
Autor:
Xiaolan Xu, Chensi Wu, Zhuoqi Lou, Chunting Peng, Lushun Jiang, Tianxian Wu, Taiwen Zeng, Yin Dong, Bing Ruan
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background This study aimed to estimate hepatitis B incidence and chronicity risk in rural adults in China under the background of eliminating viral hepatitis. Methods Hepatitis B surface antigen (HBsAg) screening was conducted every 2 years
Externí odkaz:
https://doaj.org/article/6cd68b579b604cbb8584a00e06c603c1
Autor:
Li Zhang, Jing Liu, Mingxia Deng, Xiangliu Chen, Lushun Jiang, Jiajie Zhang, Lisheng Tao, Wei Yu, Yunqing Qiu
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Enterococcus faecalis (Efa) has been shown to be a “driver bacteria” in the occurrence and development of colorectal cancer (CRC). This study aims to explore the effect of specific metabolites of Efa on CRC. Methods The pro-tu
Externí odkaz:
https://doaj.org/article/c805baeed55949369a9f2a2aae74e980
Autor:
Xiaolan Xu, Chensi Wu, Lushun Jiang, Chunting Peng, Liya Pan, Xue Zhang, Wei Shen, Lin Chen, Zhuoqi Lou, Kaijin Xu, Lanjuan Li, Yin Dong, Bing Ruan
Publikováno v:
International Journal of Health Policy and Management, Vol 11, Iss 10, Pp 2115-2123 (2022)
Background Chronic hepatitis B (CHB) is highly prevalent among adults in rural China and better management of those populations is of vital importance for viral hepatitis elimination. Adult immunization has been the subject of much controversy in pre
Externí odkaz:
https://doaj.org/article/18af0c9816234324b1cbb312aaeab9b3
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Recent advancements in the field of artificial intelligence have demonstrated success in a variety of clinical tasks secondary to the development and application of big data, supercomputing, sensor networks, brain science, and other technologies. How
Externí odkaz:
https://doaj.org/article/6efe952bdbee4d8db24bcb76616a000d
Autor:
Yaqiong Zhan, Lushun Jiang, Xuehang Jin, Shuaibing Ying, Zhe Wu, Li Wang, Wei Yu, Jiepeng Tong, Li Zhang, Yan Lou, Yunqing Qiu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 110996- (2021)
RRM2, the small subunit of ribonucleotide reductase, is identified as a tumor promotor and therapeutic target. It is common to see the overexpression of RRM2 in chemo-resistant cancer cells and patients. RRM2 mediates the resistance of many chemother
Externí odkaz:
https://doaj.org/article/e948f89f19d045f4a6eb6ae82f490767
Autor:
Zhe Wu, Yaqiong Zhan, Li Wang, Jiepeng Tong, Li Zhang, Mengjia Lin, Xuehang Jin, Lushun Jiang, Yan Lou, Yunqing Qiu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 130, Iss , Pp 110556- (2020)
Backgrounds: Ribonucleotide reductase (RR) catalyzes the essential step in the formation of all four deoxynucleotides. Upregulated activity of RR plays an active role in tumor progression. As the regulatory subunit of RR, ribonucleotide reductase sub
Externí odkaz:
https://doaj.org/article/81cf2bdf8c2741c28023a37e3d4305d8
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 125, Iss , Pp 110033- (2020)
Objectives: BZG as a novel multitarget kinase inhibitor, has been proved to inhibit the proliferation of hepatocellular carcinoma (HCC) previously. In this study, we aimed at investigating the underlying mechanisms of BZG with and without sorafenib a
Externí odkaz:
https://doaj.org/article/d6d31b71a1b74995a89fdbd7778aef5d
Autor:
Yingsha Chen, Shuaibing Ying, Lushun Jiang, Shaohua Dong, Jinyao Dai, Xuehang Jin, Wei Yu, Yunqing Qiu
Publikováno v:
Infection and Drug Resistance. 15:1317-1328
Yingsha Chen,1,2 Shuaibing Ying,1 Lushun Jiang,1 Shaohua Dong,1 Jinyao Dai,1 Xuehang Jin,1 Wei Yu,1 Yunqing Qiu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d611ec58674cda49821d7e0fd594f46
https://doi.org/10.2147/idr.s349236
https://doi.org/10.2147/idr.s349236